Solaris Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Solaris Asset Management's GILD Position: Q4 2017 in Review
Solaris Asset Management sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 850 shares — an estimated $69K sold.
Solaris Asset Management first reported a position in GILD in Q4 2013 and held it in 16 quarters. The position peaked at $4.23M in Q2 2015. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.
- Solaris Asset Management reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
- Solaris Asset Management sold 850 Gilead Sciences shares in Q4 2017, an estimated $69K.
- Solaris Asset Management first reported a position in Gilead Sciences in Q4 2013 and held it in 16 quarters.
- Solaris Asset Management's Gilead Sciences position peaked at $4.23M in Q2 2015.
- 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.
Based on Solaris Asset Management's 13F filing for Q4 2017, filed 16 Jan 2018.